The Acute Influence of Acid Suppression with Esomeprazole on Gastrointestinal Microbiota and Brain Gene Expression Profiles in a Murine Model of Restraint Stress

Neuroscience ◽  
2019 ◽  
Vol 398 ◽  
pp. 206-217 ◽  
Author(s):  
Robert MacLaren ◽  
Richard A. Radcliffe ◽  
Edward T. Van Matre ◽  
Charles E. Robertson ◽  
Diana Ir ◽  
...  
2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Carl Grant Mangleburg ◽  
Timothy Wu ◽  
Hari K. Yalamanchili ◽  
Caiwei Guo ◽  
Yi-Chen Hsieh ◽  
...  

Abstract Background Tau neurofibrillary tangle pathology characterizes Alzheimer’s disease and other neurodegenerative tauopathies. Brain gene expression profiles can reveal mechanisms; however, few studies have systematically examined both the transcriptome and proteome or differentiated Tau- versus age-dependent changes. Methods Paired, longitudinal RNA-sequencing and mass-spectrometry were performed in a Drosophila model of tauopathy, based on pan-neuronal expression of human wildtype Tau (TauWT) or a mutant form causing frontotemporal dementia (TauR406W). Tau-induced, differentially expressed transcripts and proteins were examined cross-sectionally or using linear regression and adjusting for age. Hierarchical clustering was performed to highlight network perturbations, and we examined overlaps with human brain gene expression profiles in tauopathy. Results TauWT induced 1514 and 213 differentially expressed transcripts and proteins, respectively. TauR406W had a substantially greater impact, causing changes in 5494 transcripts and 697 proteins. There was a ~ 70% overlap between age- and Tau-induced changes and our analyses reveal pervasive bi-directional interactions. Strikingly, 42% of Tau-induced transcripts were discordant in the proteome, showing opposite direction of change. Tau-responsive gene expression networks strongly implicate innate immune activation. Cross-species analyses pinpoint human brain gene perturbations specifically triggered by Tau pathology and/or aging, and further differentiate between disease amplifying and protective changes. Conclusions Our results comprise a powerful, cross-species functional genomics resource for tauopathy, revealing Tau-mediated disruption of gene expression, including dynamic, age-dependent interactions between the brain transcriptome and proteome.


2017 ◽  
Vol 312 (5) ◽  
pp. G488-G497 ◽  
Author(s):  
J. A. Nolan ◽  
P. Skuse ◽  
K. Govindarajan ◽  
E. Patterson ◽  
N. Konstantinidou ◽  
...  

Statins are the most widely prescribed medications worldwide for the treatment of hypercholesterolemia. They inhibit the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-R), an enzyme involved in cholesterol synthesis in higher organisms and in isoprenoid biosynthesis in some bacteria. We hypothesized that statins may influence the microbial community in the gut through either direct inhibition or indirect mechanisms involving alterations to host responses. We therefore examined the impact of rosuvastatin (RSV) on the community structure of the murine gastrointestinal microbiota. RSV was orally administered to mice and the effects on the gut microbiota, host bile acid profiles, and markers of inflammation were analyzed. RSV significantly influenced the microbial community in both the cecum and feces, causing a significant decrease in α-diversity in the cecum and resulting in a reduction of several physiologically relevant bacterial groups. RSV treatment of mice significantly affected bile acid metabolism and impacted expression of inflammatory markers known to influence microbial community structure (including RegIIIγ and Camp) in the gut. This study suggests that a commonly used statin (RSV) leads to an altered gut microbial composition in normal mice with attendant impacts on local gene expression profiles, a finding that should prompt further studies to investigate the implications of statins for gut microbiota stability and health in humans. NEW & NOTEWORTHY This work demonstrates that rosuvastatin administration in mice affects the gastrointestinal microbiota, influences bile acid metabolism, and alters transcription of genes encoding factors involved in gut homeostasis and immunity in the gastrointestinal tract.


2018 ◽  
Vol 27 (20) ◽  
pp. 4136-4151 ◽  
Author(s):  
Claudia Kasper ◽  
Francois Olivier Hebert ◽  
Nadia Aubin-Horth ◽  
Barbara Taborsky

Stroke ◽  
2021 ◽  
Vol 52 (Suppl_1) ◽  
Author(s):  
George K Wong

Objective: Gait variability analysis has been adopted in clinical settings to characterize the presentation of various neurological diseases. However, literature and practice lack a comprehensive murine model assessment of the gait deficits that result from subarachnoid hemorrhage (SAH). Further, correlations between gait parameters and the gene expression profiles associated with SAH have yet to be identified. The present study quantitatively assesses gait deficits through a clinically relevant murine model of SAH to determine associations between gait deficits and SAH-related gene expressions. Methods: A total of 159 dynamic and static gait parameters from the endovascular perforation murine model for simulating clinical human SAH were measured using the CatWalk system. Pearson’s correlation analysis was applied, and 88 genes associated with SAH were identified from the Ingenuity Pathway Analysis database to aid the investigation of the relationship between gait variability and gene expression profiles. Results: Eighty gait parameters and the mRNA expression levels of 35 of the 88 SAH-associated genes exhibited significant change in the SAH models (p < 0.05). Totals of 42 and 38 gait parameters correlated with the 35 SAH-associated genes positively and negatively with Pearson’s correlation coefficients of > 0.7 and < -0.7, respectively. p-SP1 453 expression in the motor cortex in SAH animal models displays a significant correlation with a subset of gait parameters associated with muscular strength and coordination of limb movements. Conclusion: This examination of gait variability and its strong correlation to gene expression profiles provides a quantitative and reliable assessment of the SAH model’s motor performance. This research provides valuable insights into the study of disease progression and offers novel therapeutic interventions in the murine modeling of SAH. p-SP1 453 expression could act as a biomarker to monitor SAH pathological development and a therapeutic target for SAH.


2009 ◽  
Vol 401 (1-2) ◽  
pp. 90-99 ◽  
Author(s):  
Joo-Won Park ◽  
Eun-Sook Park ◽  
Eun Nam Choi ◽  
Hae-Young Park ◽  
Sung-Chul Jung

Sign in / Sign up

Export Citation Format

Share Document